Wird geladen...
Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
BACKGROUND: Esophageal cancer remains one of the hardest cancers to treat with rising incidence rates, low overall survival and high levels of treatment resistance. The lack of clinically available biomarkers hinder diagnosis and treatment stratification. While large scale sequencing approaches have...
Gespeichert in:
| Veröffentlicht in: | PLoS One |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Public Library of Science
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136712/ https://ncbi.nlm.nih.gov/pubmed/30212533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0203173 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|